Issued Patents All Time
Showing 1–25 of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12331037 | Pyrimidines as EGFR-inhibitors and methods of treating disorders | Nathanael S. Gray, Hwan Geun Choi, Jaebong Jang | 2025-06-17 |
| 12233128 | Degraders that target ALK and therapeutic uses thereof | Nathanael S. Gray, John Hatcher, Chelsea E. Powell | 2025-02-25 |
| 12006555 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson +4 more | 2024-06-11 |
| 11945816 | Inhibitors of EGFR and/or HER2 and methods of use | John Hatcher, Nathanael S. Gray, Jaebong Jang, Dries De Clercq, Jamie A. Saxon +3 more | 2024-04-02 |
| 11858897 | Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK | John Hatcher, Nathanael S. Gray, Hwangeun Choi, Tinghu Zhang | 2024-01-02 |
| 11814379 | Cyano quinoline amide compounds as HER2 inhibitors and methods of use | Nathanael S. Gray, Jaebong Jang, Jieun Son | 2023-11-14 |
| 11673882 | Pyrimidines as EGFR inhibitors and methods of treating disorders | Nathanael S. Gray, Hwan Geun Choi, Jaebong Jang | 2023-06-13 |
| 11584746 | Inhibitors of EGFR and methods of use thereof | Nathanael S. Gray, Dries De Clercq, Jaebong Jang, Ciric To, Michael Eck +2 more | 2023-02-21 |
| 11186574 | Inhibitors of EGFR and/or HER2 and methods of use | John Hatcher, Nathanael S. Gray, Jaebong Jang, Dries De Clercq, Jamie A. Saxon +3 more | 2021-11-30 |
| 11161842 | Bifunctional molecules for degradation of EGFR and methods of use | Nathanael S. Gray, Jaebong Jang, Dries De Clercq, Michael Eck | 2021-11-02 |
| 11066363 | Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK | John Hatcher, Nathanael S. Gray, Hwangeun Choi, Tinghu Zhang | 2021-07-20 |
| 11009508 | Methods of diagnosing and prognosing lung cancer | Kwok-Kin Wong, Bruce E. Johnson, Hongbin Ji, Nabeel Bardeesy, Norman E. Sharpless +1 more | 2021-05-18 |
| 11008620 | Methods for treating cancer resistant to ErbB therapeutics | Jeffrey Engelman, Lewis C. Cantley | 2021-05-18 |
| 10870636 | Pyrimidines as EGFR inhibitors and methods of treating disorders | Nathanael S. Gray, Hwan Geun Choi, Jaebong Jang | 2020-12-22 |
| 10865451 | Non-invasive blood based monitoring of genomic alterations in cancer | Cloud P. Paweletz, Geoffrey R. OXNARD, Yanan Kuang | 2020-12-15 |
| 10836722 | Inhibitors of EGFR and methods of use thereof | Nathanael S. Gray, Michael Eck, Hwan Geun Choi, Jaebong Jang, Kwok-Kin Wong | 2020-11-17 |
| RE48175 | Hydrophobically tagged small molecules as inducers of protein degradation | Nathanael S. Gray, Ting Xie, Sang-Min Lim, Craig M. Crews | 2020-08-25 |
| 10669589 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson +4 more | 2020-06-02 |
| 10550112 | Pyrimidines as EGFR inhibitors and methods of treating disorders | Nathanael S. Gray, Jaebong Jang | 2020-02-04 |
| 10508082 | Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK | John Hatcher, Nathanael S. Gray, Hwan Geun Choi, Tinghu Zhang | 2019-12-17 |
| 10450310 | Bifunctional molecules for degradation of EGFR and methods of use | Nathanael S. Gray, Jaebong Jang, Dries De Clercq, Michael Eck | 2019-10-22 |
| 10385019 | Inhibitors of EGFR and methods of use thereof | Nathanael S. Gray, Michael Eck, Hwan Geun Choi, Jaebong Jang, Kwok-Kin Wong | 2019-08-20 |
| 10266517 | Pyrimidines as EGFR inhibitors and methods of treating disorders | Nathanael S. Gray, Hwan Geun Choi, Jaebong Jang | 2019-04-23 |
| 10000815 | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments | Daphne Winifred Bell, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson +4 more | 2018-06-19 |
| 9908884 | EGFR inhibitors and methods of treating disorders | Nathanael S. Gray, Michael Eck, Wenjun Zhou | 2018-03-06 |